Congrats to Big Pharma on Finding a New Way to Profit Off of HIV Prevention
Gilead, the company that makes Truvada, just got FDA approval for Descovy, another form of PrEP. It costs nearly $1,800 a month without insurance coverage.
How I Make My Mixed HIV Status Relationship Work
I'm HIV positive, but my partner is not. And though science has rendered that difference medically negligible, it's hard to shed decades of stigma overnight.
Why Nobody's Funding the HIV-Prevention Strategy Ten Times More Effective than PrEP
TasP—or Treatment as Prevention—aims to promote awareness that it's incredibly difficult to get HIV from someone who's undetectable. But that idea is proving a hard pill to swallow
This Doctor Is Fighting the AIDS Epidemic Spreading Among Black Men
Few populations are more at risk of contracting HIV than black men in Jackson, Mississippi. Dr. Leandro Mena runs a clinic there that fights back against this crisis.
10 Questions You Always Wanted to Ask a Person Who Is HIV Positive
"I don't think I need curing. I take one pill a day, and that being enough to stop me transmitting it, I feel that's all the cure I need."